First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas (Q37281257)
Jump to navigation
Jump to search
scientific article published on October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas |
scientific article published on October 2016 |
Statements
1 reference
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas (English)
1 reference
A Patnaik
1 reference
L J Appleman
1 reference
A W Tolcher
1 reference
K P Papadopoulos
1 reference
M Beeram
1 reference
D W Rasco
1 reference
G J Weiss
1 reference
J C Sachdev
1 reference
M Chadha
1 reference
M Fulk
1 reference
S Ejadi
1 reference
J M Mountz
1 reference
M T Lotze
1 reference
F G S Toledo
1 reference
E Chu
1 reference
M Jeffers
1 reference
C Peña
1 reference
C Xia
1 reference
S Reif
1 reference
I Genvresse
1 reference
R K Ramanathan
1 reference
1 reference
Identifiers
1 reference